Color Study (High-Risk Breast Lesions) - Clinical Trial

What is the Purpose of this Study?

Treatment

If you choose to join this study, you will:
- Give a saliva sample
- Have a genetic test using the Color Genomics 30 gene hereditary panel test

What is the Condition Being Studied?
Objective

Genetic Testing

Who Can Participate in the Study?

Key Eligibility

Women diagnosed with high-risk breast lesions including:
- Lobular carcinoma in situ (LCIS)
- Atypical ductal hyperplasia (ADH)
- Atypical lobular hyperplasia (ALH)
- Flat epithelial atypia (FEA)
- Columnar cell hyperplasia (CCH)

Age Group
Adults

What is Involved?

Description

We are doing this study to screen women diagnosed with high-risk breast lesions for genetic mutations that may be linked to a future risk of cancer.

Study Details

Full Title
Genetic testing for women with high-risk breast lesions
Principal Investigator
Surgical Oncologist
Protocol Number
IRB: PRO00089223
NCT: NCT00000000
Phase
Phase N/A
ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate